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Background
Nowadays, the use of plants for large-scale production of
recombinant proteins is gaining wider acceptance because
of their many practical, economic and safety advantages,
compared with traditional microbial and animal produc-
tion systems.
However, production systems that use whole plants to
express recombinant proteins may lack several of the
intrinsic benefits of cultured cells, such as the precise con-
trol over growth conditions. Plant cell cultures may com-
bine the merits of plant systems with those of microbial
and animal cell cultures [1]. Optimization of environ-
mental conditions in culture could be used to enhance
foreign protein synthesis and stability, reducing the total
cost of protein production. Moreover, a great advantage of
synthesizing recombinant proteins in plant cell cultures is
the very simple procedure of product purification, espe-
cially when the product is secreted into the liquid culture
medium. As well as the potential commercial benefits, in
vitro systems also represent an important tool for study-
ing the process of foreign protein synthesis, assembly,
secretion and turnover in plant cells and tissue.
Results
Recently, we have proposed the legume model plant Med-
icago tuncatula as a promising production system [2]. In
this work, specifically, several suspension cell lines were
established from transformed M. truncatula plants
expressing two valuable recombinant proteins from dif-
ferent sources, human Erythropoietin (EPO) and fungal
phytase. For both proteins two versions were available,
one where the protein is secreted and the other where it is
retained in the Endoplasmic Reticulum (ER).
Callus induction was achieved through incisions using a
sharp razor blade (perpendicular to the mid-vein of the
folioles) and the abaxial side of the folioles was main-
tained in contact with the medium with appropriate
growth regulators. Calli were kept at 23°C in the dark on
solid media for approximately two months. When calli
reached the appropriate size, cells were transferred to
Erlenmeyer flasks with shosen medium, kept with agita-
tion in the dark at 24°C, and subcultured to fresh
medium every week (A.S. Pires, unpublished results).
Identification of recombinant EPO or phytase was per-
formed by Western blot analysis, showing that different
cell suspension lines exhibit different expression levels of
recombinant protein. Interestingly, we observed that in
some cell lines with higher expression levels of the
secreted version of recombinant protein, part of it is not
being secreted to the medium. On the other hand, in sus-
pension cells generated from transgenic plants engineered
to produce recombinant protein targeted to the ER, the
proteins are not being totally retained. These results are
probably related with stress imposed to the cell by high
expression levels of a foreign protein.
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Preliminary immunolocalization analysis, using electron
microscopy, revealed that in those cell lines with different
expression levels, the subcellular localization of the
recombinant protein is significantly different as well as
the subcellular structure itself. As we can see in Figure 1,
in phytase higher expressor cells, anti-phytase signal is
located on unidentified structures under the cell wall but
in the lower expressor cells the labelling is concentrated in
apparently lytic vacuoles. We hope these studies will help
us to answer the following question: is it the cell morphol-
ogy that determines the subcellular fate of the product or
the opposite?
In order to compare the obtained results with other plant
based systems, leaves from transgenic M. truncatula origi-
nal plants and transgenic BY2 Tobacco Suspension Cul-
ture expressing the same recombinant proteins were also
analysed.
Conclusion
Similarly to M. truncatula leaves [2], results obtained for
cell suspension cultures established from this plant also
indicate that this alternative could be highly suited for the
production of recombinant proteins, with all the advan-
tages widely recognized for plant cell cultures. Further
studies, including the systematic analysis of pos-transla-
tional modifications of the recombinant proteins pro-
duced by this system, are still required to improve its
potential to compete with other expression platforms for
production of valuable recombinant proteins.
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Electron microscope images of subcellular localization of recombinant phytase in plant cells harvested from three different sus-pension cell lines establish d from M. truncatula plants: a wild type, a hig er expressor and a low r xp essor of this recom-binant proteinFigu e 1
Electron microscope images of subcellular localization of recombinant phytase in plant cells harvested from three different sus-
pension cell lines established from M. truncatula plants: a wild type, a higher expressor and a lower expressor of this recom-
binant protein.Page 2 of 2
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